1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Netherlands Pharmaceuticals and Healthcare Report Q3 2015

Netherlands Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 113 pages

Includes 3 FREE quarterly updates

BMI View:
The healthcare market in the Netherlands will continue to offer considerable commercialopportunities. As a part of the Health Insurance Act, implemented in 2006, private insurance for curativecare and supplemental benefits is mandatory for the entire population. However, the Act is based on theprinciples of managed competition: insurers and providers of care compete on price and quality while thegovernment has set certain rules to guarantee universal access to good-quality care - creating a highlycompetitive business environment and acting as a challenge to company revenue streams.
Headline Expenditure Projections
- Pharmaceuticals: EUR5.92bn (USD7.93bn) in 2014 to EUR5.85bn (USD6.43bn) in 2015; -1.2% inlocal currency terms and -18.9% in US dollar terms. Forecast in line with last quarter.- Healthcare: EUR73.31bn (USD98.23bn) in 2014 to EUR74.73bn (USD82.20bn) in 2015; +1.9% in localcurrency terms and -16.3% in US dollar terms. Forecast revised upwards from last quarter due to therelease of WHO confirmed data.

Table Of Contents

Netherlands Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ...... 7
SWOT ............ 9
Political .......... 11
Economic ........ 12
Operational Risk ............. 13
Industry Forecast ..... 14
Pharmaceutical Market Forecast ....... 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2011-2019) . 16
Healthcare Market Forecast ............. 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) . . . 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) . 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) 21
Prescription Drug Market Forecast ... 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) . . . 23
Patented Drug Market Forecast ........ 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) . 25
Generic Drug Market Forecast ......... 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) . . 27
OTC Medicine Market Forecast ........ 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) . . . 30
Pharmaceutical Trade Forecast ........ 30
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2013-2019) . 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2013-2019) . . . 32
Key Risks To BMI's Forecast Scenario 33
Macroeconomic Forecasts ..... 35
Economic Analysis ........... 35
Table: GDP Contribution To Growth (Netherlands 2012-2020) . . . 41
Industry Risk Reward Ratings 42
Western Europe Risk/Reward Index ... 42
Netherlands Risk/Reward Index ......... 46
Rewards ........ 46
Risks ............. 47
Market Overview ...... 48
Industry Trends And Developments ..... 49
Epidemiology . 49
Healthcare Sector .......... 51
Table: Healthcare Resources (Netherlands 2009-2014) . . . . . 53
Table: Healthcare Personnel (Netherlands 2009-2014) 53
Table: Healthcare Activity (Netherlands 2009-2014) . . 54
Healthcare Funding ........ 54
Health Insurance ........... 54
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006 56
Healthcare Insurance Developments . 59
Table: Biosimilars Approved In The EU . . . . 59
Research And Development ............. 60
Clinical Trials 62
Biotechnology 65
Regulatory Development ........ 67
Regulatory Developments 68
Intellectual Property Regime ........... 70
Pricing Regime .............. 70
Reimbursement Regime ... 73
Competitive Landscape .......... 75
Pharmaceutical Industry . 75
Table: Pharmaceutical Production, 1995-2010 (EUR '000s) 75
Recent Company Activity . 77
Pharmaceutical Wholesale Sector .... 78
Pharmaceutical Retail Sector .......... 79
Company Profile ....... 82
DSM .............. 82
Qiagen ........... 85
Pharming Group ............. 88
Merck and Co ..... 91
Pfizer ............. 93
GlaxoSmithKline ............. 95
Sanofi ............. 97
Novartis .......... 99
Demographic Forecast ......... 102
Demographic Outlook .... 102
Table: Population Headline Indicators (Netherlands 1990-2025) 103
Table: Key Population Ratios (Netherlands 1990-2025) . . . . 103
Table: Urban/Rural Population and Life Expectancy (Netherlands 1990-2025) . . . . . 104
Table: Population By Age Group (Netherlands 1990-2025) 104
Table: Population By Age Group % (Netherlands 1990-2025) . . . 105
Glossary ... 107
Methodology ........... 109
Pharmaceutical Expenditure Forecast Model .. 109
Healthcare Expenditure Forecast Model ......... 109
Notes On Methodology .. 110
Risk/Reward Index Methodology .... 111
Index Overview ............ 112
Table: Pharmaceutical Risk/Reward Index Indicators 112
Indicator Weightings .... 113

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

  • $ 6 650
  • Industry report
  • May 2015
  • by BCC Research

This BCC Research study provides an in-depth analysis and forecast of selected areas of the global healthcare acquired infections (HAI) market. The report offers forecasts by treatment segment and type ...

US Pharmaceutical Chemicals Market

US Pharmaceutical Chemicals Market

  • $ 5 200
  • Industry report
  • June 2015
  • by Freedonia

US demand to increase 6.1% annually through 2019 US demand for pharmaceutical chemicals is forecast to rise 6.1 percent annually to $54 billion in 2019. Merchant market sales primarily to generic drug ...

Phenoxyethanol Preservatives Market for Home and Personal Care, Pharmaceuticals, Dyes & Inks and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Phenoxyethanol Preservatives Market for Home and Personal Care, Pharmaceuticals, Dyes & Inks and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • $ 4 795
  • Industry report
  • April 2015
  • by Transparency Market Research

Phenoxyethanol preservatives are a type of mono alkyl ethers, which are formed when ethylene oxide reacts with 2-Phenol. These are also obtained naturally from green tea. Phenoxyethanol preservatives possess ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.